Keyphrases
β-Thalassemia (β-thal)
100%
Clinical Aspects
100%
Recent Advances
100%
Bone Disease
100%
Osteoporosis
77%
Pathogenic Mechanism
22%
Endocrine Complications
22%
Osteopenia
22%
Bone Mass
22%
Testosterone
11%
Patient Management
11%
Diabetes
11%
Early childhood
11%
Insulin-like Growth factor-1
11%
Aging
11%
Gender Differences
11%
Estrogen
11%
Iron Toxicity
11%
Osteoclast
11%
Bone Loss
11%
Osteoblast
11%
Bone Formation
11%
Puberty
11%
Vitamin D Deficiency
11%
Delayed Puberty
11%
Hypogonadotropic Hypogonadism
11%
Disease Complications
11%
Osteoblastic
11%
Anabolic Effect
11%
Hypogonadism
11%
Bone Fracture
11%
Secretory Dysfunction
11%
Skeletal Structures
11%
Endocrinopathy
11%
Biphosphonates
11%
Osteoblastic Bone Formation
11%
Hypoparathyroidism
11%
Chronic Anemia
11%
Hypothyroidism
11%
Therapeutic Measures
11%
Osteoclastic Bone Resorption
11%
Osteoclastic Activity
11%
Late Treatment
11%
Bone Deterioration
11%
RANK-RANKL-OPG
11%
Puberty Induction
11%
Microarchitecture
11%
Medicine and Dentistry
Clinical Feature
100%
Thalassemia Major
100%
Bone Disease
100%
Osteoporosis
77%
Bone Mass
22%
Ossification
22%
Osteopenia
22%
Disease
11%
Diabetes
11%
Drug Therapy
11%
Prevalence
11%
Deterioration
11%
Anemia
11%
Vitamin D Deficiency
11%
Hypovitaminosis D
11%
Delayed Puberty
11%
Hypogonadotropic Hypogonadism
11%
Hypothyroidism
11%
Bisphosphonate
11%
Osteoclast
11%
Hypogonadism
11%
Fracture
11%
Endocrine Disease
11%
Osteoclast Differentiation Factor
11%
Osteolysis
11%
Heidelberg Retinal Tomography
11%
Sex Difference
11%
Hypoparathyroidism
11%
Iron Overload
11%
Osteoblast
11%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Feature
100%
Thalassemia Major
100%
Bone Disease
100%
Osteopenia
22%
Disease
11%
Syndrome
11%
Prevalence
11%
Anemia
11%
Deterioration
11%
Iron Poisoning
11%
Osteoclast Differentiation Factor
11%
Hypovitaminosis D
11%
Vitamin D Deficiency
11%
Bisphosphonic Acid Derivative
11%
Endocrine Disease
11%
Hypoparathyroidism
11%
Hypogonadism
11%
Hypothyroidism
11%
Hypogonadotropic Hypogonadism
11%
Delayed Puberty
11%